HM-178: Assessing Methods for Improvement in Methotrexate Toxicity Management and Detection of Central Nervous System Involvement of Aggressive Lymphoma

NCT04668768 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

3

Enrollment

OTHER

Sponsor class

Stopped To be terminated due to slow accrual, patient still in follow up

Conditions

Lymphoma

Interventions

DRUG: Glucarpidase

Sponsor

Fox Chase Cancer Center